Interaction between IGF2-PI3K axis and cancer-associated-fibroblasts promotes anal squamous carcinogenesis.


Journal

International journal of cancer
ISSN: 1097-0215
Titre abrégé: Int J Cancer
Pays: United States
ID NLM: 0042124

Informations de publication

Date de publication:
01 10 2019
Historique:
received: 01 06 2018
revised: 03 12 2018
accepted: 28 01 2019
pubmed: 5 2 2019
medline: 18 1 2020
entrez: 5 2 2019
Statut: ppublish

Résumé

Anal squamous cell carcinoma (ASCC) is a rare tumour, but its incidence is increasing. Standard chemoradiotherapy fails to cure 20% of patients and no targeted therapy is currently approved for recurrent ASCC. The PI3K/Akt/mTOR pathway is frequently altered in this poorly characterised carcinoma

Identifiants

pubmed: 30714617
doi: 10.1002/ijc.32178
doi:

Substances chimiques

IGF2 protein, human 0
Insulin-Like Growth Factor II 67763-97-7

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

1852-1859

Informations de copyright

© 2019 UICC.

Auteurs

Wulfran Cacheux (W)

Department of Medical Oncology, Hôpital Privé Pays de Savoie, Annemasse, France.
Department of Medical Oncology, Institut Curie, PSL Research University, Saint-Cloud, France.
Faculty of Health Sciences, Versailles Saint-Quentin-en-Yvelines University, Versailles, France.

Astrid Lièvre (A)

Department of Medical Oncology, Institut Curie, PSL Research University, Saint-Cloud, France.

Sophie Richon (S)

Department of Translational Research, Institut Curie, PSL Research University, Paris, France.
UMR 144, Institut Curie, PSL Research University, CNRS, Paris, France.

Sophie Vacher (S)

Department of Genetics, Pharmacogenomics Unit, Institut Curie, PSL Research University, Paris, France.

Elsy El Alam (E)

Department of Tumour Biology, Institut Curie, PSL Research University, Saint-Cloud, France.

Adrien Briaux (A)

Department of Genetics, Pharmacogenomics Unit, Institut Curie, PSL Research University, Paris, France.

Rania El Botty (R)

Department of Translational Research, Institut Curie, PSL Research University, Paris, France.

Pascale Mariani (P)

Department of Surgical Oncology, Institut Curie, PSL Research University, Paris, France.

Bruno Buecher (B)

Department of Medical Oncology, Institut Curie, PSL Research University, Saint-Cloud, France.

Anne Schnitzler (A)

Department of Genetics, Pharmacogenomics Unit, Institut Curie, PSL Research University, Paris, France.

Jorge Barbazan (J)

UMR 144, Institut Curie, PSL Research University, CNRS, Paris, France.

Sergio Roman-Roman (S)

Department of Translational Research, Institut Curie, PSL Research University, Paris, France.

Ivan Bièche (I)

Department of Genetics, Pharmacogenomics Unit, Institut Curie, PSL Research University, Paris, France.

Virginie Dangles-Marie (V)

Department of Translational Research, Institut Curie, PSL Research University, Paris, France.
Faculty of Pharmacy, Université Paris Descartes, Paris, France.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH